ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase IIIB Subcutaneous Abatacept Monotherapy Study

ClinicalTrials.gov ID: NCT00547521

Public ClinicalTrials.gov record NCT00547521. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 9:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIIb, Multi-center, Stratified, Open-Label Study to Evaluate the Immunogenicity, Steady State Trough Level, and Safety of Subcutaneous Abatacept (BMS-188667) in Subjects With Rheumatoid Arthritis Administered With or Without Background Methotrexate

Study identification

NCT ID
NCT00547521
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
119 participants

Conditions and interventions

Interventions

  • Methotrexate (MTX) Drug
  • abatacept Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2007
Primary completion
Nov 30, 2008
Completion
Jan 31, 2014
Last update posted
Mar 22, 2015

2007 – 2014

United States locations

U.S. sites
15
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
Rheumatology Associates Of North Alabama Huntsville Alabama 35801
Coastal Clinical Research Inc Mobile Alabama 36608
Stanford University School Of Medicine Palo Alto California 94304
Boulder Medical Center Boulder Colorado 80304
The Arthritis Center Palm Harbor Florida 34684
Medical Towers South Louisville Kentucky 40298
Westroads Medical Group Omaha Nebraska 68114
Regional Rheumatology Associates Binghamton New York 13905
Physicians East, Pa Greenville North Carolina 27834
Healthcare Research Consultants Tulsa Oklahoma 74135
East Penn Rheumatology Associates Bethlehem Pennsylvania 18015
Altoona Center For Clinical Research Duncansville Pennsylvania 16635
Low Country Rheumatology, Pa Charleston South Carolina 29406
Columbia Arthritis Center Columbia South Carolina 29204
Rheumatic Disease Center Glendale Wisconsin 53217

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00547521, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 22, 2015 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00547521 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →